Penders et al., 2021 - Google Patents
Single particle automated Raman trapping analysis of breast cancer cell-derived extracellular vesicles as cancer biomarkersPenders et al., 2021
View PDF- Document ID
- 16290332922256655396
- Author
- Penders J
- Nagelkerke A
- Cunnane E
- Pedersen S
- Pence I
- Coombes R
- Stevens M
- Publication year
- Publication venue
- ACS nano
External Links
Snippet
Extracellular vesicles (EVs) secreted by cancer cells provide an important insight into cancer biology and could be leveraged to enhance diagnostics and disease monitoring. This paper details a high-throughput label-free extracellular vesicle analysis approach to study …
- 238000001069 Raman spectroscopy 0 title abstract description 118
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/65—Raman scattering
- G01N2021/653—Coherent methods [CARS]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Penders et al. | Single particle automated Raman trapping analysis of breast cancer cell-derived extracellular vesicles as cancer biomarkers | |
Carmicheal et al. | Label-free characterization of exosome via surface enhanced Raman spectroscopy for the early detection of pancreatic cancer | |
Shin et al. | Correlation between cancerous exosomes and protein markers based on surface-enhanced Raman spectroscopy (SERS) and principal component analysis (PCA) | |
Panikar et al. | Towards translation of surface-enhanced Raman spectroscopy (SERS) to clinical practice: Progress and trends | |
Shin et al. | Early-stage lung cancer diagnosis by deep learning-based spectroscopic analysis of circulating exosomes | |
Lee et al. | Multiplexed profiling of single extracellular vesicles | |
Shao et al. | New technologies for analysis of extracellular vesicles | |
Wu et al. | Dual-aptamer modified graphene field-effect transistor nanosensor for label-free and specific detection of hepatocellular carcinoma-derived microvesicles | |
Yan et al. | A label-free platform for identification of exosomes from different sources | |
Rojalin et al. | Hybrid nanoplasmonic porous biomaterial scaffold for liquid biopsy diagnostics using extracellular vesicles | |
Etayash et al. | Real-time detection of breast cancer cells using peptide-functionalized microcantilever arrays | |
Kast et al. | Emerging technology: applications of Raman spectroscopy for prostate cancer | |
Lu et al. | Biotin-triggered decomposable immunomagnetic beads for capture and release of circulating tumor cells | |
Wu et al. | Rapid label-free isolation of circulating tumor cells from patients’ peripheral blood using electrically charged Fe3O4 nanoparticles | |
Nie et al. | Folic acid targeting for efficient isolation and detection of ovarian cancer CTCs from human whole blood based on two-step binding strategy | |
Peng et al. | Peptide-functionalized nanomaterials for the efficient isolation of HER2-positive circulating tumor cells | |
Machálková et al. | Drug penetration analysis in 3D cell cultures using fiducial-based semiautomatic coregistration of MALDI MSI and immunofluorescence images | |
Amrollahi et al. | Ultra-sensitive automated profiling of EpCAM expression on tumor-derived extracellular vesicles | |
Yin et al. | Graphene sensor arrays for rapid and accurate detection of pancreatic cancer exosomes in patients’ blood plasma samples | |
Wang et al. | Characterizing the heterogeneity of small extracellular vesicle populations in multiple cancer types via an ultrasensitive chip | |
Sobral-Filho et al. | Ex vivo detection of circulating tumor cells from whole blood by direct nanoparticle visualization | |
Li et al. | Dual-aptamer-targeted immunomagnetic nanoparticles to accurately explore the correlations between circulating tumor cells and gastric cancer | |
Xiao et al. | Intelligent probabilistic system for digital tracing cellular origin of individual clinical extracellular vesicles | |
Ishwar et al. | Glioblastoma associated natural killer cell EVs generating tumour-specific signatures: noninvasive GBM liquid biopsy with self-functionalized quantum probes | |
Xiao et al. | Accurate and Convenient Lung Cancer Diagnosis through Detection of Extracellular Vesicle Membrane Proteins via Förster Resonance Energy Transfer |